NIAGEN BIOSCIENCE, INC. Amortization of Debt Issuance Costs
NIAGEN BIOSCIENCE, INC. (NAGE) reported Amortization of Debt Issuance Costs of $0 for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2020-11-04
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for the quarter ending 2019-12-31 was $0.00.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for the quarter ending 2019-09-30 was $294.00K.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for the quarter ending 2018-12-31 was $0.00.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for fiscal 2019 was $846.00K.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for fiscal 2018 was $0.00.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for fiscal 2016 was $41.00K, a 241.67% increase from fiscal 2015.
- NIAGEN BIOSCIENCE, INC. amortization of debt issuance costs for fiscal 2015 was $12.00K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $0.00 10-Q · filed 2020-11-04 | |||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $294.00K derived: sum of 2 quarters · filed 2020-11-04 | $846.00K 10-K · filed 2020-03-10 | ||
| 2019-09-30 | $294.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $846.00K 10-Q · filed 2020-11-04 | |||
| 2019-06-30 | $552.00K 10-Q · filed 2020-08-06 | ||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $0.00 derived: sum of 2 quarters · filed 2020-03-10 | $0.00 10-K · filed 2020-03-10 | ||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $0.00 10-Q · filed 2019-11-12 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | ||||
| 2016-01-02 | $41.00K 10-K · filed 2016-03-17 | ||||
| 2015-01-03 | $12.00K 10-K · filed 2016-03-17 | $11.51K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |